805
Views
75
CrossRef citations to date
0
Altmetric
Research Article

Morbidity Related to Axillary Irradiation in the Treatment of Breast Cancer

&
Pages 337-347 | Published online: 08 Jul 2009

References

  • Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
  • Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62.
  • Hellman S. Stopping metastases at their source. N Engl J Med 1997; 337: 996–7.
  • Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335–9.
  • Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391–8.
  • Bentzen SM, Overgaard M. Clinical radiobiology and nor-mal-tissue morbidity after breast cancer treatment. In: Altman KI, Lett JT, eds. Advances in radiation biology, vol. 18. San Diego: Academic Press, 1994: 25–51.
  • Bentzen SM. Towards evidence-based radiation oncology: improving the design, analysis, and reporting of clinical out-come studies in radiotherapy. Radiother Oncol 1998; 46: 5–18.
  • Bentzen SM, Overgaard M, Thames HD. Fractionation sensi-tivity of a functional endpoint: impaired shoulder movement after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 1989; 17: 531–7.
  • Dische S, Warburton MF, Jones D, Lartigau E. The record-ing of morbidity related to radiotherapy. Radiother Oncol 1989; 16: 103–8.
  • Gerber LH. A review of measures of lymphedema. Cancer 1998; 83: 2803–4.
  • Petrek J, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998; 83: 2776–81.
  • Olsen NK, Pfeiffer P, Johannsen L, Schroder H, Rose C. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993; 26: 43–9.
  • Mondrup K, Olsen NK, Pfeiffer P, Rose C. Clinical and electrodiagnostic findings in breast cancer patients with radia-tion-induced brachial plexus neuropathy. Acta Neurol Scand 1990; 81: 153–8.
  • Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 1998; 83: 1362–8.
  • Kiel KD, Rademacker AW. Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 1996; 198: 279–83.
  • Zuppinger A. Spdtveränderungen nach protrahiert-fraktion-ierter Röntgenbestrahlung im Bereich der Oberen Luft- und Speisewege. Strahlentherapie 1941; 70: 361–442.
  • Turesson I. The progression rate of late radiation effects in normal tissues and its impact on dose-response relationships. Radiother Oncol 1989; 15: 217–26.
  • Bentzen SM, Thames HD, Overgaard M. Latent-time estima-tion for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 1989; 15: 267–74.
  • Bentzen SM, Vaeth M, Pedersen D, Overgaard J. Why actu-arial estimates should be used in reporting late normal-tissue effects of cancer treatment ... NOW. Int J Radiat Oncol Biol Phys 1995; 32: 1531–4.
  • Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother Oncol 1994; 32: 1–11.
  • Bentzen SM, Tucker SL. Quantifying the steepness of dose-re-sponse curves. Int J Radiat Biol 1997; 71: 531–42.
  • Withers HR. Biologic basis of radiation therapy. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 2nd ed. Philadelphia: JB Lippincott Company, 1992: 64–96.
  • Thames HD, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose frac-tionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8: 219–26.
  • Bentzen SM. Quantitative clinical radiobiology. Acta Oncol 1993; 32: 259–75.
  • Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 years' follow-up. Radiother Oncol 1989; 15: 169–88.
  • Ellis F. Dose, time and fractionation: a clinical hypothesis. Clin Radiol 1969; 20: 1–7.
  • Bentzen SM, Overgaard J. Time-dose relationships in radio-therapy. In: Steel GG, ed. Basic clinical radiobiology. Lon-don: Edward Arnold, 1993: 47–54.
  • Bentzen SM, Overgaard J. Clinical normal-tissue radiobiol-ogy. In: Tobias JS, Thomas PRM, eds. Current radiation oncology. London: Arnold, 1996: 37–67.
  • Svensson H, Westling P, Larsson L-G. Radiation-induced lesions of the brachial plexus correlated to the dose-time-frac-tionation schedule. Acta Radiol Ther Phys Biol 1975; 14: 228–38.
  • Ryoo MC, Kagan AR, Wollin M, et al. Prognostic factors for recurrence and cosmesis in 393 patients after radiation ther-apy for early mammary carcinoma. Radiology 1989; 172: 555–9.
  • Dische S, Saunders MI, Williams C, Hopkins A, Aird E. Precision in reporting the dose given in a course of radiother-apy. Radiother Oncol 1993; 29: 287–93.
  • Bentzen SM, Christensen JJ, Overgaard J, Overgaard M. Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmas-tectomy radiotherapy. Acta Oncol 1988; 27: 105–16.
  • Gagliardi G, Lax I, Soderstrom S, Gyenes G, Rutqvist LE. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. RadiotherOncol 1998; 46: 63–71.
  • Notter G, Hallberg 0, Vikterlöf KJ. Strahlenshäden am Plexus brachialis bei Patienten mit Mammakarzinom. Strahlenther Onkol 1970; 139: 538–43.
  • Marshall MG. Three-field isocentric breast irradiation using asymmetric jaws and a tilt board. Radiother Oncol 1993; 28: 228–32.
  • Lebesque JV. Field matching in breast irradiation: an exact solution to a geometrical problem. Radiother Oncol 1986; 5: 47–57.
  • Lichter AS, Fraass BA, van de Geijn J, Padikal TN. A technique for field matching in primary breast irradiation. Int J Radiat Oncol Biol Phys 1983; 9: 263–70.
  • Hunt MA, Kutcher GJ, Martel MK. Matchline dosimetry of a three-field technique for breast treatment using cobalt or 6 MV x-rays. Int J Radiat Oncol Biol Phys 1987; 13: 1099–106.
  • Idzes MH, Holmberg 0, Mijnheer BJ, Huizenga H. Effect of set-up uncertainties on the dose distribution in the match region of supraclavicular and tangential breast fields. Radio-ther Oncol 1998; 46: 91–8.
  • Hopewell JW, van der Kogel AJ. Volume effect in spinal cord. Authors' reply. Br J Radiol 1988; 61: 973–5.
  • Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated ap-proach. Oncology 1993; 50: 445–9.
  • Meek AG. Breast radiotherapy and lymphedema. Cancer 1998; 83: 2788–97.
  • Kissin MW, Querci DR, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580–4.
  • Sugden EM, Rezvani M, Harrison JM, Hughes LK. Shoulder movement after the treatment of early stage breast cancer. Clin Oncol 1998; 10: 173–81.
  • von der Maase H. Complications of combined radiotherapy and chemotherapy. Sem Rad Oncol 1994; 4: 81–94.
  • Fowble B. Interaction of chemotherapy and radiation in the treatment of nonmetastatic breast cancer. In: Meyer JL, Vaeth JM, eds. Radiotherapy/chemotherapy interactions in cancer therapy. Frontiers in radiationtherapy and oncology, vol 26. Basel: Karger, 1992: 95–114.
  • Bentzen SM, Overgaard M, Thames HD, Christensen JJ, Overgaard J. Early and late normal-tissue injury after post-mastectomy radiotherapy alone or combined with chemother-apy. Int .1- Radiat Biol 1989; 56: 711–5.
  • Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Ra-diotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996; 88: 918–22.
  • Grainger DJ, Metcalfe JC. Tamoxifen: teaching an old drug new tricks? Nat Med 1996; 2: 381–5.
  • Border WA, Noble NA. Transforming growth factor /3 in tissue fibrosis. N Engl J Med 1994; 331: 1286–92.
  • Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S. TGF-beta 1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibro-sis. Int J Cancer 1999; 84: 155–9.
  • Gin i SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor /3 on bleomycin-induced accumu-lation of lung collagen in mice. Thorax 1993; 48: 959–66.
  • Wazer DE, Mon J, Erban JK, Schmid CH, Ruthazer R, Schmidt-Ullrich RK. The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 1997; 80: 732–40.
  • Fowble B, Fein DA, Hanlon AL, et al. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast can-cer. Int J Radiat Oncol Biol Phys 1996; 35: 669–77.
  • Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma [see comments]. J Clin Oncol 1992; 10: 356–63.
  • Bentzen SM, Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal-tissue injury. Sem Rad Oncol 1994; 4: 68–80.
  • Baumann M. Impact of endogenous and exogenous factors on radiation sequelae. In: Dunst J, Sauer R, eds. Radiation sequelae. Berlin-Heidelberg: Springer-Verlag, 1995: 3–12.
  • Liljegren G, Holmberg L. Arm morbidity after sector resec-tion and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a ran-domised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 1997; 33: 193–9.
  • Robertson JM, Clarke DH, Pevzner MM, Matter RC. Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 1991; 68: 502–8.
  • Ross JG, Hussey DH, Mayr NA, Davis CS. Acute and late reactions to radiation therapy in patients with collagen vascu-lar diseases. Cancer 1993; 71: 3744–52.
  • Johansen J, Bentzen SM, Overgaard J, Overgaard M. Rela-tionship between the in vitro radiosensitivity of skin fibrob-lasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radio-ther Oncol 1996; 40: 101–9.
  • Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Prospec-tive comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1993; 27: 1173–9.
  • Bentzen SM, Hendry JH. Variability in the radiosensitivityof normal cells and tissues. Report from a workshop organised by the European Society for Therapeutic Radiology and Oncology in Edinburgh, UK, 19 September 1998. Int J Radiat Biol 1999; 75: 513–7.
  • Bentzen SM. Potential clinical impact of normal-tissue intrin-sic radiosensitivity testing. Radiother Oncol 1997; 43: 121–31.
  • Sikora K. Enraged about radiotherapy. Br Med J 1994; 308: 188–9.
  • Dische S, Joslin CA, Miller S, Bell NL, Holmes JC. The breast radiation injury litigation and the clinical oncologist. Clin Oncol 1998; 10: 367–71.
  • Snider H, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998; 176: 305–10.
  • Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer--a multicenter validation study. N Engl J Med 1998; 339: 941–6.
  • Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5: 126–30.
  • Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guide-lines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275–83.
  • Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [see comments]. Lancet 1997; 349: 1864–7.
  • Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345–50.
  • Segerstrom K, Bjerle P, Henriksson TG, Nystrom A. Decom-pression of the axillary vein for oedema of the arm caused by axillary dissection and irradiation. Scand J Plast Reconstr Surg Hand Surg 1991; 25: 245–8.
  • Mortimer PS. The pathophysiology of lymphedema. Cancer 1998; 83: 2798–802.
  • Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and pheripheral nerves. Int J Radiat Oncol Biol Phys 1995; 31: 1309–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.